The prostate is the genital organ most commonly affected by benign and malignant neoplasms. Benign enlargement of the prostate gland is an extremely common process that occurs in nearly all men with functioning testes.
The term benign prostate enlargement is defined as prostate growth sufficient to obstruct (block) the urethral outlet, resulting in bothersome lower urinary tract symptoms (LUTS), urinary tract infection (UTI), hematuria or compromised upper urinary tract function. Nevertheless, the term benign prostatic hyperplasia (BPH), defined as a non malignant histologic growth of the glandular elements of the prostate. Histologic evidence of prostate enlargement begins about the third decade of life and increases proportionally with aging. It refers to an abnormal increase in the number of normal cells in the prostate along with increased contraction of the smooth muscle elements of the prostatic stroma. It becomes a disorder when enlargement obstructs the urinary channel and causes changes in the urinary tract with associated
Please also read, Nursing Care Plans for Benign Prostatic Hyperplasia